Brief: Merus NV To Pay Genmab $240 Million Termination Fee Under Certain Conditions If Deal Falls Through - SEC Filing
Sept 29 (Reuters) - SEC Filing: MERUS NV: IF DEAL IS TERMINATED UNDER SOME CIRCUMSTANCES, CO TO PAY GENMAB A TERMINATION FEE OF $240 MILLION - SEC FILING MERUS NV: IF DEAL IS TERMINATED UNDER SOME CIRCUMSTANCES, GENMAB TO PAY REGULATORY TERMINATION FEE OF $416 MILLION TO CO- SEC FILING Source text: [ID:n0001193125-25-221807] Further company coverage: 2GH.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos